fig2

Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma

Figure 2. Signaling pathways regulating the activity and levels of MITF, a key transcription factor. MITF: Microphthalmia-associated transcription factor; PD-L1: programmed death-ligand 1; PI3K: phosphoinositide 3-kinase; ATF3/CCL4: activating transcription factor 3/macrophage inflammatory protein-1 beta; Wnt: signaling proteins; GF: growth factor receptor.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/